India keen to resume Covid-19 vaccine export to Bangladesh, says envoy

India's Commissioner to Bangladesh on Sunday said that the country is keen to resume the export of Covid vaccines to Dhaka as soon as possible, but there is no word yet when it will resume the export

vaccination, coronavirus, covid-19, vaccine
ANI Asia
2 min read Last Updated : Jun 21 2021 | 7:50 AM IST

India's Commissioner to Bangladesh Vikram Doraiswami on Sunday said that the country is keen to resume the export of COVID-19 vaccines to Dhaka as soon as possible, but there is no word yet when it will resume the export.

"We hope the problem will be resolved soon," Doraiswami told reporters after a meeting with Awami Jubo League Chairman Fazle Shams Parash in Bangladesh, reported Dhaka Tribune.

"The corona situation in India is still at a dangerous stage. So we are not yet able to say the exact time of giving vaccines to Bangladesh," he added.

On the other hand, Parash recalled India's crucial help during the 1971 Liberation War and said India has always been by Bangladesh's side in everything. "India is our friend of bad days and partner in good days as well," he said.

Parash said that he discussed with the Indian envoy about the current coronavirus situation in India.

According to Dhaka Tribune, Doraiswami watched two documentaries on the humanitarian activities of the ruling party's youth wing during the COVID-19 pandemic.

Bangladesh had started its inoculation drive against coronavirus with the Oxford-AstraZeneca vaccine procured from India at USD 5 per dose. However, due to the devastating second wave of the COVID-19 pandemic in India, vaccine exports have temporarily come to a halt.

Meanwhile, Bangladesh is also experiencing an alarming rise in fresh COVID-19 related deaths and new cases. The health authorities had also detected the presence of the Delta variant of the coronavirus, which is highly contagious.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirus VaccineBangladeshExport

First Published: Jun 21 2021 | 7:50 AM IST

Next Story